News follows recent regulatory authorizations to proceed with the trial in Brazil and the Philippines
INOVIO and partner Advaccine are collaborating on the global Phase 3 trial in regions underserved by COVID-19 vaccines; to focus on Latin America, Asia, and Africa
https://finance.yahoo.com/news/inovio-receives-regulatory-authorization-conduct-120000867.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.